UCSF Develops Research as a Care Option Decision, Supporting Tool for Prostate Cancer Patients

UCSF Develops Research as a Care Option Decision Support Tool for Prostate Cancer Patients

One of the biggest challenges facing clinical trial sponsors and investigational sites centers on the efficient identification, recruitment and ongoing retention of sufficient numbers of participants, whether they be patients in a novel therapeutic study to volunteers for new vaccine studies. For the former, that is the finding and retaining of patients for therapeutic-focused research, a growing trend, points to the concept of clinical research as a care option. That is, that various processes, workflows and clinician-facing decision tools can be developed to help promote more awareness, access and ultimately participation to research itself. The modifications to system and process raise therapeutic area implications—that, is they must emphasize more awareness and access by therapeutic area and specific condition. Recently, a professor of medicine from the University of California, San Francisco (UCSF), presented a clinical facing decision tool to help generate more awareness and access in the area of prostate cancer. Presented at the virtual 2021 ASCO Genitourinary Cancers Symposium, Dr. Hala Borno, a medical oncologist, shared how at UCSF they designed a novel technology soluti...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee